doi: 10.1038/s41593-019-0539-4 149 Gruden.PoklarU
2000 Apr;46(2):111-3.] Use in mom would primarily cause improved redox in mom, and have a minor detox effect
Altered B12 handling and reduced clearance in kidney disease, and both cellular release and reduced clearance in liver disease, can raise B12, so supportive renal or hepatic findings make those causes plausible
Researchers believe BPC-157 may: Promote Angiogenesis: This is the formation of new blood vessels
People with low glutathione levels or those with less efficient detoxification genes are at a higher risk of developing the associated diseases
"MOTS-c can significantly enhance physical performance in young, middle-age, and old mice." Reynolds et al., Nature Communications , 2021 [3] The ceiling on all of this is the same ceiling every mitochondrial peptide hits: the outcome data is rodent data